A novel glucagon-like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice-Reference-Cited by-同舟云学术

A novel glucagon-like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice

Published:2017-01-30 Issue:3 Volume:65 Page:950-968
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Valdecantos M. Pilar¹²,Pardo Virginia¹²,Ruiz Laura¹²,Castro-Sánchez Luis³,Lanzón Borja⁴,Fernández-Millán Elisa²⁵,García-Monzón Carmelo⁶⁷,Arroba Ana I.¹²,González-Rodríguez Águeda⁶⁷,Escrivá Fernando²⁵,Álvarez Carmen²⁵,Rupérez Francisco J.⁴,Barbas Coral⁴,Konkar Anish⁸,Naylor Jacqui⁹,Hornigold David⁹,Santos Ana Dos⁹,Bednarek Maria⁹,Grimsby Joseph⁸,Rondinone Cristina M.⁸,Valverde Ángela M.¹²

Affiliation:

1. Instituto de Investigaciones Biomédicas Alberto Sols (Centro Mixto CSIC-UAM); Madrid Spain

2. Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERdem); Instituto de Salud Carlos III; Madrid Spain

3. University of Colima; Colima Mexico

4. Centre for Metabolomics and Bioanalysis (CEMBIO); Faculty of Pharmacy, Universidad San Pablo CEU; Campus Monteprincipe Madrid Spain

5. Departamento de Bioquímica y Biología Molecular II; Facultad de Farmacia, Universidad Complutense; Madrid Spain

6. Liver Research Unit; Instituto de Investigación Sanitaria Princesa, University Hospital Santa Cristina; CIBERehd Madrid Spain

7. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III; Madrid Spain

8. MedImmune LLC; Gaithersburg MD

9. MedImmune Ltd; Cambridge UK

Funder

Ministerio de Economía y Competitividad

CIBERdem (ISCIII, Spain)

INFLAMES

European Foundation for the Study of Diabetes

Publisher

Wiley

Subject

Hepatology

Reference49 articles.

1. Management of NAFLD: a stage-based approach;Rinella;Nat Rev Gastroenterol Hepatol,2016

2. Liver transplantation and non-alcoholic fatty liver disease;Zezos;World J Gastroenterol,2014

3. Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis;Marra;Trends Mol Med,2008

4. Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas;Michalopoulos;Am J Pathol,2010

5. Surgical resection versus liver transplant for patients with hepatocellular carcinoma;Taefi;Cochrane Database Syst Rev,2013

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maladaptive regeneration and metabolic dysfunction associated steatotic liver disease: Common mechanisms and potential therapeutic targets;Biochemical Pharmacology;2024-09

2. A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis;New England Journal of Medicine;2024-07-25

3. Dual Agonists for Management of Metabolic Dysfunction–Associated Steatohepatitis;New England Journal of Medicine;2024-07-25

4. Hepatic glucagon action: beyond glucose mobilization;Physiological Reviews;2024-07-01

5. Chronic treatment with glucagon-like peptide-1 and glucagon receptor co-agonist causes weight loss-independent improvements in hepatic steatosis in mice with diet-induced obesity;Biomedicine & Pharmacotherapy;2024-07